Anthera Pharmaceuticals (OTCMKTS:ANTH) Shares Pass Above 200-Day Moving Average – Here’s What Happened

Anthera Pharmaceuticals, Inc. ( OTCMKTS:ANTH – Get Free Report )’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.

00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.



00, with a volume of 10,000 shares traded. Anthera Pharmaceuticals Trading Down 50.0 % Anthera Pharmaceuticals Company Profile ( Get Free Report ) Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.

It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. Recommended Stories Five stocks we like better than Anthera Pharmaceuticals Why Invest in 5G? How to Invest in 5G Stocks Work and Play: Investing in the Rise of Bleisure Travel How to Find Undervalued Stocks Top Dividend Stocks to Buy Now as Bond Yields Could Lower Roth IRA Calculator: Calculate Your Potential Returns SAP: AI Tailwinds Accelerating Enterprise Cloud Business Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .

.